chrisvoncsefalvay/vaers-outcomes huggingface dataset:
KNEE PAIN; INJECTION SITE PAIN; GENERAL TIREDNESS; This spontaneous report received from a patient concerned a 28 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and expiry: 19-SEP-2021) dose was not reported, administered on 13-SEP-2021 17:00 for prophylactic vaccination. No concomitant medications were reported.  On 13-SEP-2021, the patient experienced injection site pain. On 13-SEP-2021, the patient experienced general tiredness. On 14-SEP-2021, the patient experienced knee pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from injection site pain on 14-SEP-2021, and had not recovered from knee pain, and general tiredness. This report was non-serious.
Severe headache, blurred vision, fever, feeling hot, dizziness, weakness, feeling disconnected. Administered Tylenol.
shingles; This case was reported by a consumer via interactive digital media  and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.  The patient's past medical history included shingles (had twice).   In August 2021, the patient received the 1st dose of Shingles vaccine. In August 2021, less than a day after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient received Shingles vaccine and overnight got shingles all over the area of shot. The follow-up would not possible as no contact details were available.
Patient with seizure at home 20-30 minutes later  Admitted to Hospital with status epilepticus.  Normal MRI, Abnormal EEG  Started on Keppra and Phenobarbitol
describes symptoms beginning 11 days later as swelling to bilateral medial elbows, without pruritis or erythema.  The swelling on the right arm was associated with digital paresthesias of the 4th and 5th digits.  About two days had macular erythema and pruritis on medial arms, trunk, back, legs, starting small and coalesced to grew, accompanied by intense pruritis and sought care in the ED x 2. With complaint of arm swelling, had negative DX, determined not to be a venous thrombotic disorder.  On 22 Apr patient presented again to clinic and diagnosed with acute generalized urticaria. Reported rash lasted less than 24 hrs. No airway involvement. Arm swelling lasted about 1 wk.   Did report low grade fever and slight site soreness the day of vaccine that lasted less than 24 hrs.   Symptoms: URTICARIA, UNSPECIFIED(L509), EDEMA, UNSPECIFIED(R609).
AE: light headed, slight ringing in the ear(resolved), dizzy (at 10:40 am) Tx: n/a, just food and drink Outcome: juice, crackers helped resolve AE.                                 pt was discharged home.
Really bad pain in Trapezia muscles; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 30-May-2021 and was forwarded to Moderna on 31-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a non-health professional and describes the occurrence of MYALGIA (Really bad pain in Trapezia muscles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Really bad pain in Trapezia muscles). At the time of the report, MYALGIA (Really bad pain in Trapezia muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had  bad pain in Trapezius  muscles Treatment medicines were not reported.
2 nights on migraines with light headaches continuing during the day. Upset or sour stomach with pain and decreased appetite for several days. Vertigo on December 24.  Headaches starting Monday morning and continuing off and on through today, December 27.
Spoke with patient's son, stated that his mother received flu shot it was too high in arm. That she has had significant, unbearable pain since the shot. Said it was very painful & bled a lot at the time of injection. Has been to PCP and put on pain meds. Had to go to ER because pain was so bad. Had MRI, ultrasound, CT scan & diagnosed with tendonitis. She is going to physical therapy.
Patient received second dose of Moderna vaccine in Left Deltoid. Reviewed list of common adverse reactions that could occur after being vaccinated. He was instructed to stay in the lot for 15 minutes so we could observe him for any reaction. If he felt ok after 15 min., he could leave. He stayed the 15 min and then left in the vehicle. No adverse reactions noted.
Mother reported that patient had reaction to vaccines when in office with sibling. Patient's right arm swelled and lasted 4 days. His left arm was swollen with red circle around injection site and lasted 3 days. Patient's arms currently have no rash or redness. Physician notified.
pt passed out approx 1min p/vax; pulse rate strong & reg 80per min;BP 11-/50;c/o dizziness but stated felt better p/laying & elevated legs on floor x 10min;felt faint;BP 90/60;numbness in lt arm;BP 108/72;
Initially complained of pain and stiffness in arm. On 10/17/17 called to report continued discomfort, weakness, loss of strength in that extremity.
pt brought to hosp via EMS; c/o malaise, SOB; respiratory failure with hypoxia, positive for COVID, sepsis, pneumonia; placed on BiPAP; admitted; CTA showed developing PNA; treated with ABX, remdesivir, dexamethasone; bradycardic; DNR/DNI; pt's condition worsened with an increase need for O2, pt refused BiPAP and desired to transition to comfort care; pt expired in the hospital
Since the morning after receiving the vaccine, I have had cold sores on both sides of my mouth. I never had a cold sore previously.
Her eyesight was burning; Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days; Cough; body aches; fever; Was tired; This spontaneous case was reported by a consumer and describes the occurrence of VISUAL IMPAIRMENT (Her eyesight was burning), VEIN DISORDER (Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days), COUGH (Cough), MYALGIA (body aches) and PYREXIA (fever) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040AMA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced VISUAL IMPAIRMENT (Her eyesight was burning), VEIN DISORDER (Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days), COUGH (Cough), MYALGIA (body aches), PYREXIA (fever) and FATIGUE (Was tired). The patient was treated with NAPROXEN SODIUM (NAPROXEN [NAPROXEN SODIUM]) on 24-Mar-2021 at a dose of 500 mg. On 25-Mar-2021, VISUAL IMPAIRMENT (Her eyesight was burning), COUGH (Cough), MYALGIA (body aches), PYREXIA (fever) and FATIGUE (Was tired) outcome was unknown. At the time of the report, VEIN DISORDER (Developed like ¨some ball of veins and swelling on the back of her left feet, of about 4 or 5 cm, that lasted 2 or 3 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Patient concomitant medications was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow-up information received on 20-APR-2021 HCP Information , patient details , Events were added .
Pain in arm  Pain spreads down arm to hand and up back to shoulder  Sometimes numbness in hand and arm Pain started as mild and sporadic has progressed to constant and often debilitating
Child was admitted 11/13/2002 to the hospital on Mon. A spinal tab was performed to rule out menigitis which proved negative for germs and bacteria. The spinal tab did show pleocytosis ( in Famaution of spinal fluid) Child now has upper extremity flaciddity. MRI of bracheal spinal cord done. Nov 19. 2002   11:30am. Phone call from MD . She states a pediatric pt was admitted on Nov 13,2002 to hospital because of weakness in arms. they suspect the child may have had an adverse vaccine event. The child received a DTAP, IPV, Comax on Nov 4, 2002 at the health dept. The child was carried to hospital because of weakness in arms on Nov 13, 2002 and was then transferred to picu. the child received a full work up. Meninigitis was suspected. a spinal tab was performed which proved negative for virus and bacteria including herpes PCR. the spinal fluid did show inflammation. The child was transferred to the pediatric floor on Nov 15,2002. The child cannot move his arms. He can move his left fingers spontaneously. Spinal fluid has been submitted foe enterovirus exam. MD stated they suspect the brachial neuritis might be due: 1. injury to arms. 2. hypersensitivity to vaccine. MD stated she is the resident and another MD is the attending physician.  60-day Follow up on 11/03/2003: "A 60 day follow up on this case was provided to VAERS on 04/03/2003.  Please see attached copy of transmitted letter and 60-day follow up form.  Telephone conversation with MD, attending pediatric physician.  She states that patients neuritis was determined to the caused from child abuse and was not vaccine related." Follow up on 06/24/04 states: "Please see attached copy of 60-day follow up report. Any questions should be addressed to the attending physician.  MD states that pts neuritis was determined to be caused from child abuse and was not vaccine related."
One week after the first injection I developed some blurring of right eye but I thought I just needed new glasses. One week after the second injection I rapidly developed severe loss of vision in the right eye. I have been evaluated medically and was found to have right optic neuritis with significant loss of vision in the right eye. I had injection site redness and swelling after both injections and moderate flu-like symptoms for a day after the second injection
65 YOF contacted the pharmacy on 11/29/2021  informing us she had severe stiffness beginning approximately 32 hours after injection. Patient stated she had shooting pain radiating from her left shoulder down her spine and into her hips. Patient also stated she has great difficulty sitting up in bed due to the severe pain that she had been experiencing Patient went to chiropractor who informed her the symptoms she was experiencing was due to the Moderna booster. Patient was advised to seek medical attention due to her progressively worsening. symptoms.
Body aches; temperature 99.7; Chills; This is a spontaneous report from a non-contactable nurse (patient herself). A 36-year-old female patient (non-pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot: EL0140), via intramuscular on 08Jan2021 09:45 in right arm at single dose for COVID-19 immunization. Medical history included thyroid cancer, appendectomy, tonsillectomy and asthma. The patient was known allergies: PCN and Sulfa. Concomitant medication included levothyroxine sodium (SYNTHROID), ibuprofen (MOTRIN), paracetamol (TYLENOL), naproxen sodium (ALEVE) and ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). The patient previously took the first dose of BNT162B2 (lot# lot: EL0140) via intramuscular on 18Dec2020 09:45 in right arm at single dose for COVID-19 immunization. The patient had no COVID prior vaccination and was not tested COVID post vaccination. The patient experienced body aches, temperature 99.7 and chills on 08Jan2021 20:00. Outcome of events were recovered in Jan2021. No treatment was received for events.   No follow up attempts are possible. No further information is expected.
Information has been received from a physician concerning a 14 year old female who on an unspecified date was vaccinated with Gardasil (yeast). It was reported that the patient was sitting on a bench and when the personnel left the room, the patient apparently fainted and ended up falling off bench. It was reported that it was unsure if the patient had broken her nose but there was blood. At the time of this report, the outcome of the events were unknown. The physician feels that the patient "might be anorexic and had not had anything to eat all day hence the fainting". No further information is available.  This is in follow-up to report (s) previously submitted on 12/14/2006.  Initial and follow up information has been received from a physician concerning a 16 year old (previously reported as 14 year old) white female.  On 07-NOV-2006, at 10:02 AM, the patient was vaccinated intramuscularly with the first dose of GARDASIL (Lot # 653735/0688F).  On 07-NOV-2006, at 10:03 AM, the patient was sitting on a bench and when the personnel left the room, the patient fainted and ended up falling off the bench.  It was reported that the patient had hit her nose when she fell and developed a small laceration (previously reported that it was unsure if the patient had broken her nose but there was blood).  The patient came to quickly with no other sequelae.  It was reported that the patient had not eaten breakfast.  On 07-NOV-2006, the patient had recovered from the events.  The physician feels that the patient "might be anorexic and had not had anything to eat all day hence the fainting".  No further information is available.
Site: Swelling at Injection Site-Mild, Systemic: Body Aches Generalized-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Headache-Severe, Systemic: Unable to Sleep-Severe, Additional Details: on 1st dose pfizer, 08/30 2 weeks, very bad headache, body ache angle ache, for 2 weeks, monthly period skipped, 2nd dose, 10/08/21, 2weeks  later, extreme severe, persistent heacache, body ache, and jaw, teethache for 2 weeks, always on lefy side of my body, which is injection site, can not sleep without medcine, have to see dentitist, now pain slowly going down
Patient reports blood in urine; This spontaneous case was reported by a pharmacist and describes the occurrence of HAEMATURIA (Patient reports blood in urine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included WARFARIN for an unknown indication.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HAEMATURIA (Patient reports blood in urine). At the time of the report, HAEMATURIA (Patient reports blood in urine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Treatment information was reported.   This case was linked to MOD-2022-525792 (Patient Link).
Neck ache at first, chills, fever up to 104, aching all over, lasting 3 days.
Pt recvd vax & exp elevated gamma-glutamyl transferase & elevated liver functions;
FLU LIKE SYMPTOMS; FATIGUE; HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included penicillin allergy, and concurrent conditions included hypertension. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 201A21A, expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced fatigue, headache, and flu like symptoms. Laboratory data (dates unspecified) included: Coronavirus test (NR: not provided) Negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fatigue, headache, and flu like symptoms. This report was non-serious.
One week after  I received the bivalent vaccine I experienced pain in my left leg and left hip. This also happened after I had my second Moderna booster in April. This last time the joint pain is more severe. After the shot in April the pain lasted until August and then gradually improved.
Nausea, vomiting, muscular aches, headache, cold chills,
soreness in arm; Vaccination site pruritus; Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided). Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] from 21-Jan-2021 to an unknown date for Prenatal care.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 19-Dec-2020 and the estimated date of delivery was 25-Sep-2021. On an unknown date, the patient experienced PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  ninth week of the pregnancy.  At the time of the report, PAIN IN EXTREMITY (soreness in arm), VACCINATION SITE PRURITUS (Vaccination site pruritus) and EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Jan-2021, Pregnancy test: positive (Positive) positive. On 21-Jan-2021, Blood test: normal (normal) normal. On 21-Jan-2021, Glucose tolerance test: normal (normal) normal. On 21-Jan-2021, Urine analysis: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
2 HOURS AFTER INJECTION I COULD WALK.  I LAID ON THE COUCH TOOK A NAP., WHEN I WOKE UP HAD A HEADACHE AND.  STILL COULDN'T WALK. I ROLLED AROUND ON THE FLOOR AND FINALLY HAD MY KIDS HELP ME UP.  FELT NAUSEOUS THROUGH UP ANY BREAKFAST, WENT BACK TO SLEEP.  TOOK THE NEXT DAY OFF FROM WORK, STILL COULDNT WALK.  THAT NIGHT THE BOTTOM OF MY LAGS AND FEET WERE STINGING AND THROBING AND HAVE CONTINUED TO HURT EVER SINCE .  EVERY NIGHT MY LEGS HURT AND FEET STING.  ALSO ABOUT 3 WEEKS LATER MY UPPER LIP WAS DEAD.
Swelling, pain and a redness at injection site that has spread down the better part of my upper arm. My doctor requested to see me  I was seen at on 4/27-they said it was Covid arm. I was told to ice it, take tylenol or advil for the pain and to monitor my symptoms. I was advised to call or go to urgent care if it gets worse, doesn't get better or I develop anymore symptoms such as a fever, chills etc
Kinrix administered to 2 months old; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 2-month-old patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 23rd August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 23rd August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 24-AUG-2022 Reporter's comments: The reporter stated that the Kinrix was administered to 2 month old patient. No other details available. The reporter consented to follow up. Additional Supportive Information: The two month old patient received a dose of Kinrix, which led to inappropriate age at vaccine administration.
Localized skin reaction at the injection site; Spontaneous report received on 10JUN2019.  An office staff member reported that a patient (unknown demographics) developed localized skin reaction at the BioThrax injection site. It was reported that patient received BioThrax couple of weeks ago but the reporter was not sure about the dates as he did not have access to the patient's medical record. At the time of the report the patient was under the observation of a physician. The reporter did not have any additional details to provide. Outcome of the event was unknown.  Company Comment: The Company considers the event of localized skin reaction to be possibly related to the BioThrax injection.  Due to the lack of additional information at this time, a definitive causal relationship is difficult to determine.  Localized injection reactions which this may represent are know to occur following injection with BioThrax; Sender's Comments: The Company considers the event of localized skin reaction to be possibly related to the BioThrax injection.  Due to the lack of additional information at this time, a definitive causal relationship is difficult to determine.  Localized injection reactions which this may represent are know to occur following injection with BioThrax
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that on an unknown dates an unspecified number of patients received doses of GARDASIL (route, dose, frequency and lot # not reported) that were improperly stored. No adverse experiences reported. No further information provided. This is one of several reports from the same source. Additional information has been requested.